GOLETA, California—Inogen, Inc., a medical technology company specializing in respiratory products for homecare use, announced the launch of VoxiTM 5, a new stationary oxygen concentrator (SOC) designed to enhance access to oxygen therapy for long-term care patients in the United States. As the latest addition to Inogen's product portfolio, Voxi 5 augments the company’s line of portable oxygen concentrators, significantly expanding the market potential while leveraging existing sales channels.
Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking stationary oxygen therapy, delivering 1-5 L/min of quiet, pure, continuous flow oxygen in a compact design. The device also features caster wheels to allow for movement between rooms in the home.
“With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients,” said Kevin Smith, president and CEO. “This launch exemplifies our commitment to innovation, affordability and enhancing the quality of life for those dependent on oxygen therapy.”
Key Features
- Quiet Operation: Promoting a home environment
- Compact Design: Includes lockable casters for ease of movement
- 3-Year Sieve Bed Warranty: Providing reliable, long-term performance
- Advanced Filtration: Features an eight-layer internal gas pathway for delivering medical-grade oxygen
The Voxi 5 is available for purchase through Inogen’s website and authorized partners. For more information, visit inogen.com/products.